23 August 2007
Appointment of Adviser on Pain Relief
Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for the consumer healthcare market, is pleased to announce the appointment of Professor Robert Moore DSc as an advisory consultant to the Company in the therapeutic area of pain relief. Prof Moore's extensive experience of pain relief, from both academic and commercial perspectives, is expected to be of great value in the development of TPR100, Futura's topical treatment for the provision of pain relief.
Prof Moore, a former Consultant Biochemist at the Radcliffe Infirmary, Oxford, has published many scientific articles. He moved into industry in 1985 as managing director of the UK division of a US diagnostics company, taking it from six to 250 employees and achieving profitability. In 1994, he established his own healthcare consultancy, which has worked for many of the world's leading pharmaceutical companies, and he has also advised Government.
Prof Moore is the founder and Editor-in-Chief of Bandolier, an independent journal on evidence based healthcare whose electronic version, www.ebandolier.com, receives more than one million visitors each month. In 1994, he was appointed Honorary Professor at the Department of Health Sciences, University of Wales.
James Barder, Futura's Chief Executive, said: “I am delighted to welcome a scientific adviser of Prof Moore's calibre to Futura. His huge breadth of experience, particularly in the area of pain relief, will be of great value in the development of TPR100, our pipeline product that uses our topical trans-dermal delivery technology, DermaSys®.”
For any further information please contact:
Futura Medical plc
James Barder, Chief Executive
Anthony Clayden, Finance Director
+44 (0) 1483 685 670
james.barder@futuramedical.co.uk
www.futuramedical.co.uk
Canaccord Adams
Mark Ashurst / Tyler Broda
Tel: + 44 (0) 20 7050 6500
For any media enquiries please contact:
Buchanan Communications Limited
Mark Court
markc@buchanan.uk.com
Rebecca Dietrich
rebeccad@buchanan.uk.com
+44 (0) 20 7466 5000
Notes
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.